Financial Fitness Check: Examining EyePoint Pharmaceuticals Inc (EYPT)’s Key Ratios

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

In the latest session, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) closed at $8.28 down -1.66%% from its previous closing price of $8.42. In other words, the price has decreased by -$1.66% from its previous closing price. On the day, 0.58 million shares were traded.

Ratios:

For a deeper understanding of EyePoint Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.79 and its Current Ratio is at 7.85. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on June 17, 2025, initiated with a Outperform rating and assigned the stock a target price of $28.

On January 07, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $33.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 19 ’25 when Zaderej Karen L. bought 5,000 shares for $5.99 per share. The transaction valued at 29,950 led to the insider holds 36,500 shares of the business.

Zaderej Karen L. bought 5,000 shares of EYPT for $29,050 on May 16 ’25. The Director now owns 31,500 shares after completing the transaction at $5.81 per share. On May 15 ’25, another insider, Zaderej Karen L., who serves as the Director of the company, bought 5,000 shares for $5.47 each. As a result, the insider paid 27,350 and bolstered with 26,500 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 10.17 while its Price-to-Book (P/B) ratio in mrq is 1.91.

Stock Price History:

Over the past 52 weeks, EYPT has reached a high of $13.98, while it has fallen to a 52-week low of $3.91. The 50-Day Moving Average of the stock is 19.76%, while the 200-Day Moving Average is calculated to be 6.51%.

Shares Statistics:

A total of 68.81M shares are outstanding, with a floating share count of 59.81M. Insiders hold about 13.08% of the company’s shares, while institutions hold 96.94% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.